On April 24, 2018 Johnson & Johnson (NYSE: JNJ) reported that it will participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference on Wednesday, May 9th, at The InterContinental Boston. Mathai Mammen, MD, Ph.D., Global Head, Research & Development, Janssen Research and Development will represent the Company in a session scheduled at 9:20 a.m. (Eastern Time) (Press release, Johnson & Johnson, APR 24, 2018, View Source [SID1234525641]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.